As research advances, unravelling the nuanced relationship between PIK3CA alterations and TNBC cell motility contributes not only to our understanding of metastasis but also holds promise for developing targeted therapies aimed at impeding the metastatic cascade in this challenging breast cancer subtype. Here, PIK3CA is linked to breast carcinoma.